Zimmer Biomet Holdings (ZBH) Liabilities and Shareholders Equity (2016 - 2025)
Zimmer Biomet Holdings has reported Liabilities and Shareholders Equity over the past 17 years, most recently at $23.1 billion for Q4 2025.
- Quarterly results put Liabilities and Shareholders Equity at $23.1 billion for Q4 2025, up 8.08% from a year ago — trailing twelve months through Dec 2025 was $91.6 billion (up 6.47% YoY), and the annual figure for FY2025 was $23.1 billion, up 8.08%.
- Liabilities and Shareholders Equity for Q4 2025 was $23.1 billion at Zimmer Biomet Holdings, down from $23.5 billion in the prior quarter.
- Over the last five years, Liabilities and Shareholders Equity for ZBH hit a ceiling of $24.2 billion in Q2 2021 and a floor of $21.1 billion in Q4 2022.
- Median Liabilities and Shareholders Equity over the past 5 years was $21.6 billion (2022), compared with a mean of $22.2 billion.
- Biggest five-year swings in Liabilities and Shareholders Equity: decreased 11.44% in 2022 and later increased 8.14% in 2025.
- Zimmer Biomet Holdings' Liabilities and Shareholders Equity stood at $23.5 billion in 2021, then fell by 10.19% to $21.1 billion in 2022, then rose by 2.05% to $21.5 billion in 2023, then fell by 0.61% to $21.4 billion in 2024, then increased by 8.08% to $23.1 billion in 2025.
- The last three reported values for Liabilities and Shareholders Equity were $23.1 billion (Q4 2025), $23.5 billion (Q3 2025), and $22.9 billion (Q2 2025) per Business Quant data.